Additionally, the increased levels of anti-tumor interleukins IL-4, IL-7, IL-28a, and IL-33 in miR-29 overexpressing tumors suggest a role for these microRNAs in bolstering anti-tumor immunity. This evidence concerns the gene IFNL2 and neoplasm.